Overall rank by patents
#1,144
Across all tracked assignees
USPTO PatentsView assignee record - 370 granted patents across 73 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE).
The verdict
Ivoclar holds 370 US patents across 73 technology areas, rank #1,144 of 50,000 tracked assignees.
Ivoclar Vivadent Ag has been granted 370 US utility patents between 2015 and 2025, placing Ivoclar Vivadent Ag at rank #1,144 across all assignees tracked by PlainPatent. This portfolio spans 73 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.7 claims per patent with primary concentration in A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE). As a Foreign Corporation, Ivoclar Vivadent Ag is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Ivoclar sits between Ventana Medical Systems, Inc. (371 patents, rank #1,140) and GE Video Compression, Llc (369 patents, rank #1,148) - the closest US assignees by grant volume. The composite Innovation Score of 60.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 189 grants, compared with 181 in the 2015–2019 window, a +4% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ivoclar Vivadent Ag's 15.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 73 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ivoclar Vivadent Ag against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ventana Medical Systems, Inc.
371 patents
BALL HORTICULTURAL COMPANY
370 patents
Dentsply Sirona Inc.
370 patents
EAGLE INDUSTRY CO., LTD.
370 patents
JATCO LTD
370 patents
WELCH ALLYN, INC.
370 patents
Ivoclar Vivadent AG
370 patents
AAC Optics Solutions Pte. Ltd.
369 patents
GE Video Compression, LLC
369 patents
What this shows Ivoclar holds 370 patents at rank #1,144, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,144 in granted patent volume.
Other assignees with the most granted patents in Ivoclar's primary technology class.
Ivoclar's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
61 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 30 | 8.1% |
| 2016 | 38 | 10.3% |
| 2017 | 36 | 9.7% |
| 2018 | 35 | 9.5% |
| 2019 | 42 | 11.4% |
| 2020 | 33 | 8.9% |
| 2021 | 36 | 9.7% |
| 2022 | 35 | 9.5% |
| 2023 | 35 | 9.5% |
| 2024 | 30 | 8.1% |
| 2025 | 20 | 5.4% |
Top 15 of 73 technology areas
Overall rank by patents
#1,144
Across all tracked assignees
60.9 out of 100
How to use this portfolio
Ivoclar's 370 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.